Valuing the economic benefits of complex interventions: when maximising health is not sufficient.
about
Interventions for preventing unintended repeat pregnancies among adolescentsPublic health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues.Health economics research into supporting carers of people with dementia: a systematic review of outcome measuresHidden Treasures and Secret Pitfalls: Application of the Capability Approach to ParkinsonNet.A national Programme Budgeting and Marginal Analysis (PBMA) of health improvement spending across Wales: disinvestment and reinvestment across the life course.Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?Recent advances in patient and proxy-reported quality of life research.Patient empowerment: the need to consider it as a measurable patient-reported outcome for chronic conditions.Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trialDelivery of a clinical genomics serviceConcepts of 'personalization' in personalized medicine: implications for economic evaluation.Would you test for 5000 Shillings? HIV risk and willingness to accept HIV testing in Tanzania.Assessing the validity of the ICECAP-A capability measure for adults with depression.The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic ReviewChoosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.Realism and resources: Towards more explanatory economic evaluation.What, who and when? Incorporating a discrete choice experiment into an economic evaluation.Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence.Issues surrounding the health economic evaluation of genomic technologies.Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, qualitative and realist synthesis of implementation factors and user engagement.Performing Economic Evaluation of Integrated Care: Highway to Hell or Stairway to Heaven?Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches.Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example.Patient Preferences for Pain Management in Advanced Cancer: Results from a Discrete Choice Experiment.Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence.Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction.What are the benefits and risks of using return on investment to defend public health programs?Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions.Predicting the ICECAP-O capability index from the WOMAC osteoarthritis index: is mapping onto capability from condition-specific health status questionnaires feasible?Preparing for genomic medicine: a real world demonstration of health system change.Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges.Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach.Aligning Health Economics Methods to Fit with the Changing World of Public Health.Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.The economic case for precision medicine.Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough SolutionsValuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method
P2860
Q24186801-3D40BFA7-F809-4625-90E6-69B0AC3DFA4AQ27006528-19051452-BDD6-4CF3-9DD7-1870299A937EQ27023728-911C71EB-CCA8-41B6-965B-BA21189803ADQ30379528-51E0645D-95E5-407E-B995-B05045C02A5CQ30602596-C1DE8A8F-3C60-406A-8820-0CB9E625FFACQ33665428-1282BD80-B84E-4D72-8260-5BD5F1E8167EQ34157094-0752F665-3028-4555-8EAE-78D72C224D6BQ34302892-579F723B-1E3F-49C7-AC40-F5E83A99E412Q34508518-E270AAD9-564B-4D96-9700-9078E0E900DAQ34774744-D494CD69-6A48-411D-9A8C-284D3BAD2027Q35575935-0C6C13EA-171B-47B0-B01D-31B530886981Q35967841-4C12277C-70BE-4FE7-9AD1-F05877773922Q36266693-B143937A-851D-4D9F-A917-0CA3D792D0F2Q36573343-1829C9B2-B530-4A89-ADB0-0212999CD7A3Q36871294-43BD7807-5DC5-4DD7-9ED8-B91A45084022Q37101758-A5F5DF70-98A0-4EB4-8DFD-B9AAD38471B8Q37139254-302CE02D-EAE0-49BA-BD83-A327B41072EFQ37355385-600DEA4C-3388-4880-B7F6-6A437C271F1EQ37541151-A71583DF-7EFC-4374-A814-C2BA5EDE10CFQ37704464-4BF20A72-4395-4050-B53D-35B6A6DC0F2EQ37705372-A8F75929-7B7B-4DCD-B8EF-63048B3EABE7Q38354845-A1171272-4F3F-429E-88D8-28E697DB7466Q38692558-8231E5B3-A1BC-459F-9EC2-13E4760420BFQ38744128-6C017D75-85B7-49D1-A3E2-778A1AEB24AEQ38863614-DEA5FF7C-F3A2-434A-8D53-6FFA69BEFC7DQ39011868-426DD83A-CE96-4179-ADC7-841A612C9676Q39179389-E07D3253-AC69-42C8-B9C4-15769547B4B6Q41818826-2F7DDA0C-179B-471D-8935-95C626841C50Q42116733-172AFEDF-297F-498F-8A47-E732E4BCD017Q43462074-BFC1EEAA-7BCF-4524-B49F-21451008821CQ47136129-92FDDCEF-454B-438B-9D4D-1AC7728EBF94Q47137452-A4FF2FE2-2546-4E02-9CB2-7FF85F4016AEQ47732575-CCC2793A-A5DD-4BA4-A436-FFCBC98B5650Q48041192-FCD33F6D-27A7-4D1F-89BE-A5A12879BA5AQ48165790-9A0411D8-6F76-47D2-AE79-4940628AC69FQ53290843-3D6A8D39-B838-42BF-91AB-F64036D49600Q54943893-48154F5A-14FE-4E34-9EB8-E95EA1D7C1E3Q55217201-F74FE480-8079-4C25-AD06-DABEAE545822Q57166342-AC8A0679-39A1-4149-B058-3A8654A0585EQ57206612-D1EA4842-4D5B-4EF3-AAFA-957A7248A83E
P2860
Valuing the economic benefits of complex interventions: when maximising health is not sufficient.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Valuing the economic benefits ...... sing health is not sufficient.
@en
Valuing the economic benefits ...... sing health is not sufficient.
@nl
type
label
Valuing the economic benefits ...... sing health is not sufficient.
@en
Valuing the economic benefits ...... sing health is not sufficient.
@nl
prefLabel
Valuing the economic benefits ...... sing health is not sufficient.
@en
Valuing the economic benefits ...... sing health is not sufficient.
@nl
P2860
P50
P356
P1433
P1476
Valuing the economic benefits ...... sing health is not sufficient.
@en
P2860
P304
P356
10.1002/HEC.2795
P407
P577
2012-02-06T00:00:00Z